Clinical Trial Update: Electromotive Mitomycin-C (EMDA-MMC) in Preventing Recurrences in High-risk Non-muscle-invasive Bladder Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating electromotive mitomycin-C (EMDA-MMC) to prevent recurrences in high-risk non-muscle-invasive bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Electromotive Mitomycin-C (mitomycin-C)

Snippet

Sponsor: Turku University Hospital | Conditions: Bladder Cancer | Phase 3 | Status: UNKNOWN